08.10.2012 • News

Abend New CEO at Kolb

Effective 1 October 2012, Dr. Sven Abend took over the role as CEO with Kolb. He is replacing Peter Wilkes.

Sven Abend joined Kolb in 2010 as Business Manager for one of the business lines. Since then, his responsibility increased step-wise and with that, Sven was able to get a broader and deeper understanding of Kolb, the markets and its customers.

Next to strengthening the portfolio, it will be Sven's role to continue developing the relationship with KLK.

Kolb is one of the largest alkoxylators in Europe. The company with its headquarters in Switzerland has a presence.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.